ÂÜÀòÂÒÂ×

Paramjit Kaur has a diverse and extensive work experience in the pharmaceutical industry. Paramjit is currently the Vice President of Clinical Sciences at iOnctura since 2023. Prior to this, they spent a significant portion of their career at AstraZeneca, starting in 2014. At AstraZeneca, they held various roles including Global Clinical Program Lead, Culture and Engagement Lead, and Global Development Lead in the Late Development, Oncology division. Paramjit also worked as a Medical Science professional in Oncology. From 2011 to 2014, they served as the Director of Clinical Science at Clovis Oncology, and prior to that, they were the Director of Clinical Operations in Europe at Vertex Pharmaceuticals from 2009 to 2011. Paramjit also worked at Bristol-Myers Squibb as the Disease Area Head in Virology from 2005 to 2008. Earlier in their career, they held the position of Clinical Programme Head in Immunology and Inflammation at Dainippon Sumitomo Pharma from 2003 to 2005. Paramjit began their career at GSK in a role related to Clinical Development from 1998 to 2001.

From 1985 to 1990, Paramjit Kaur attended the University of Cambridge. However, no information regarding the degree or field of study pursued is available.